SM
Subair Moorikkulam Musammil
About Subair Moorikkulam Musammil
Data last updated:
Subair Moorikkulam Musammil is a Managing Director at Billroth Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Billroth Pharmaceuticals Private Limited reported revenue of ₹54,073 (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Billroth Pharmaceuticals Private Limited U51909KL2018PTC052946 | Managing Director | 18 Apr 2018 | 2018 | ₹54,073 (FY 2019) | Active |
Board colleagues of Subair Moorikkulam Musammil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Salim Thazhmanayil Koya Kunju | 08113200 | Billroth Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subair Moorikkulam Musammil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subair Moorikkulam Musammil
Subair Moorikkulam Musammil currently holds 1 directorship: Billroth Pharmaceuticals Private Limited (Managing Director, since 18 Apr 2018, revenue ₹54,073 (FY 2019)).
Subair Moorikkulam Musammil was first appointed on 18 Apr 2018 as Managing Director at Billroth Pharmaceuticals Private Limited.
The current boards of Subair Moorikkulam Musammil's companies include Salim Thazhmanayil Koya Kunju (Billroth Pharmaceuticals Private Limited).